Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
EBIATLeasesNon-Current ReceivablesOther Gross PP&E AdjustmentsReceivables RefundsShares Issued
Ratios

Ligand Pharmaceuticals (LGND) Shares Repurchased (2016 - 2020)

Historic Shares Repurchased for Ligand Pharmaceuticals (LGND) over the last 8 years, with Q4 2020 value amounting to $4.7 million.

  • Ligand Pharmaceuticals' Shares Repurchased fell 9425.08% to $4.7 million in Q4 2020 from the same period last year, while for Sep 2021 it was $4.7 million, marking a year-over-year decrease of 9696.51%. This contributed to the annual value of $78.0 million for FY2020, which is 8278.37% down from last year.
  • Ligand Pharmaceuticals' Shares Repurchased amounted to $4.7 million in Q4 2020, which was down 9425.08% from $73.3 million recorded in Q1 2020.
  • Ligand Pharmaceuticals' 5-year Shares Repurchased high stood at $181.2 million for Q3 2019, and its period low was $502000.0 during Q1 2016.
  • In the last 5 years, Ligand Pharmaceuticals' Shares Repurchased had a median value of $50.8 million in 2018 and averaged $59.7 million.
  • As far as peak fluctuations go, Ligand Pharmaceuticals' Shares Repurchased soared by 789920.84% in 2019, and later plummeted by 9425.08% in 2020.
  • Ligand Pharmaceuticals' Shares Repurchased (Quarter) stood at $502000.0 in 2016, then soared by 291.63% to $2.0 million in 2017, then surged by 3467.7% to $70.1 million in 2018, then grew by 16.82% to $81.9 million in 2019, then plummeted by 94.25% to $4.7 million in 2020.
  • Its last three reported values are $4.7 million in Q4 2020, $73.3 million for Q1 2020, and $81.9 million during Q4 2019.